Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

308.01
Delayed Data
As of Aug 28
 -3.99 / -1.28%
Today’s Change
208.64
Today|||52-Week Range
340.34
+19.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues3.7B4.1B4.2B5.8B
 
 
 
 
 
Cost of Goods Sold1.9B1.8B1.6B2.0B
 
 
 
 
 
Depreciation And Amortization938.2M938.0M982.6M1.7B
 
 
 
 
 
 
Operating ExpensesGross Income876.5M1.3B1.6B2.0B
 
 
 
 
 
General Expenses1.2B1.5B675.6M1.8B
 
 
 
 
 
Research And Development331.1M364.6M187.3M453.0M
 
 
 
 
 
Total Operating Expenses4.0B4.3B3.3B5.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-359.0M-214.0M951.4M147.7M
 
 
 
 
 
Extraordinary Credit29.9M----20.6M
 
 
 
Extraordinary Charge-701.3M-237.6M-1.5B-371.9M
 
 
 
 
 
Interest Expense On Debt132.1M127.8M171.9M339.9M
 
 
 
 
 
Other Expenses10.2M-220.6M34.0M-8.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.2B-794.9M-690.0M-548.9M
 
 
 
 
 
Income Taxes-107.9M-62.0M-177.7M-307.3M
 
 
 
 
 
Minority Interest0.000.00-300.0K-1.5M
 
 
 
Preferred Dividend0.000.00-23.2M-69.6M
 
 
 
Net Income-1.0B-732.9M-512.0M-243.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS264.3M265.1M289.5M392.6M
 
 
 
 
 
Shares To Calculate EPS Diluted264.3M265.1M289.5M392.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.95-$2.76-$1.85-$0.80
 
 
 
 
 
EPS Diluted-$3.95-$2.76-$1.85-$0.80